1. Smith JR, Rosenbaum JT. Neurological concomitants of uveitis. Br J Ophthalmol. 2004. 88:1498–1499.
Article
2. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006. 66:1485–1489.
Article
3. Dahbour SS. MRI documented acute myelitis in a patient with Vogt-Koyanagi-Harada syndrome: first report. Clin Neurol Neurosurg. 2009. 111:200–202.
Article
4. Tang Y, Wang X, Ding Y, Li C, Jia J. Longitudinal lesion of the spinal cord in a patient with Vogt-Koyanagi-Harada disease. J Neurol Neurosurg Psychiatry. 2010. 81:941–942.
Article
5. Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995. 39:265–292.
Article
6. Fang W, Yang P. Vogt-koyanagi-harada syndrome. Curr Eye Res. 2008. 33:517–523.
Article
7. Rajendram R, Evans M, Rao NA. Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin. 2005. 45:115–134.
Article
8. Damico FM, Bezerra FT, Silva GC, Gasparin F, Yamamoto JH. New insights into Vogt-Koyanagi-Harada disease. Arq Bras Oftalmol. 2009. 72:413–420.
Article
9. Iqniebi A, Gaafar A, Sheereen A, Al-Suliman A, Mohamed G, Al-Hussein K, et al. HLA-DRB1 among patients with Vogt-Koyanagi-Harada disease in Saudi Arabia. Mol Vis. 2009. 15:1876–1880.
10. Du L, Kijlstra A, Yang P. Immune response genes in uveitis. Ocul Immunol Inflamm. 2009. 17:249–256.
Article
11. Tiercy JM, Rathinam SR, Gex-Fabry M, Baglivo E. A shared HLA-DRB1 epitope in the DR beta first domain is associated with Vogt-Koyanagi-Harada syndrome in Indian patients. Mol Vis. 2010. 16:353–358.
12. Damico FM, Cunha-Neto E, Goldberg AC, Iwai LK, Marin ML, Hammer J, et al. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1
*0405-positive and -negative Vogt-Koyanagi-Harada uveitis. Invest Ophthalmol Vis Sci. 2005. 46:2465–2471.
Article